BD

Bhaskar Das

Active Director Director DIN 06847222
DIN 06847222 First appointment Mar 2014 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Mar 2014
Shareholding value Locked Premium profile

About Bhaskar Das

Bhaskar Das has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Susruta Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06847222
Primary Designation Director
First Appointment 20 Mar 2014
Oldest Company Age 12 yrs

Current companies

Company Designation Appointment Founded Status
Director 20 Mar 2014 2013 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Susruta Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bhaskar Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhaskar Das

Bhaskar Das has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Susruta Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Bhaskar Das is associated with 1 company as Director.

Bhaskar Das has expertise in General Business.

Bhaskar Das has 12 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available